NovoCure Limited is a global oncology company that develops and commercializes innovative therapy for cancer patients. Their primary focus is on developing a treatment called Optune, which utilizes low-intensity electrical fields to potentially slow or stop the growth and division of cancer cells. NovoCure seeks to revolutionize cancer treatment options through their cutting-edge technology and commitment to improving patient outcomes.
